PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance

2012-05-02
(Press-News.org) Belmont, MA - Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs.

In an article published May 1, 2012 online in PLoS ONE, Gordana Vitaliano, MD, director of the Brain Imaging NaNoTechnology Group at the McLean Hospital Imaging Center, reported that clathrin protein, a ubiquitous protein found in human, animal, plant, bacteria and fungi cells, can been modified for use as a nanoparticle for in-vivo studies. "Clathrin has never been modified for use in vivo and offers many new and interesting possibilities for delivering drugs and medical imaging agents into the brain", said Vitaliano.

Clathrin is the body's primary delivery vehicle responsible for delivering many different types of molecules into cells. Vitaliano therefore believed that the protein's naturally potent transport capabilities might be put to practical medical use for drug delivery and medical imaging.

"This study provides a new insight into utilizing bioengineered clathrin protein as a novel nanoplatform that passes the blood brain barrier," said Vitaliano, who successfully attached different fluorescent labels, commonly used in imaging, to functionalize clathrin nanoparticles. "We were able to show that the clathrin nanoparticles could be non-invasively delivered to the central nervous system (CNS) in animals. The clathrin performed significantly."

Of major importance for future clinical applications, Vitaliano also showed that clathrin crossed and/or bypassed the blood-brain barrier without enhancers or modifications, unlike other nanoparticles. These findings open the door to exploring new and important CNS medical applications.

One important medical application for clathrin nanoparticles would be Magnetic Resonance Imaging (MRI). Gadolinium contrast agents are often used to improve MRI performance. In one configuration, Vitaliano found that functionalized clathrin nanoparticles performed 8,000 times better than an FDA approved MRI contrast agent (gadopentetate dimeglumine).

"Stated another way, it means 8,000 times less gadolinium might be required for achieving good MRI results. Because very low gadolinium concentrations would be required for MRI, it could significantly decrease gadolinium toxicity, which is an important issue," explained Vitaliano. "Clathrin transported gadolinium is therefore among the most potent, biocompatible contrast agents available."

These results in two different applications showed that clathrin offers substantial functionalization and transport flexibility. Purified clathrin nanoparticles could therefore serve as an appealing alternative to other medical nanoplatforms such as dendrimers, nanogels, solid lipid nanospheres, liposomes, and the like.

Given the critical need for new types of CNS drug transport capabilities, Vitaliano said her work would likely be of interest to researchers involved in neuroimaging and neuroscience, but also to radiologists, bioengineers, chemists, physicists, material scientists, biomedical researchers, and other researchers active at the frontiers of imaging and drug delivery.

Looking ahead, Vitaliano noted that her findings may also facilitate other studies for examining signaling pathways in different diseases that rely in whole or in part on clathrin transport, and thus may have a substantial impact in multiple fields.

### McLean Hospital is the largest psychiatric clinical care, teaching and research facility of Harvard Medical School, an affiliate of Massachusetts General Hospital and a member of Partners HealthCare. For more information about McLean Hospital, visit www.mclean.harvard.edu.


ELSE PRESS RELEASES FROM THIS DATE:

Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival

2012-05-02
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas. Sarcomas are relatively rare forms of cancer. In contrast to carcinomas, which arise from epithelial cells (in breast, colon and lung cancers, for example), sarcomas are tumors ...

Sirma Mobile Inc. Announces Release of New App That Allows Businesses to Effectively Manage Staff Attendance

2012-05-02
Sirma Mobile, Inc. today announced the release of mTimeCard, a free mobile app for both iPhone and Android that lets SMBs easily monitor their employees' timekeeping and attendance. "It is not only staff administration, but managing most of a company's marketing activities, checking inventory or dealing with suppliers, for example. A simple time-and-effort-saving solution will be highly appreciated," said business owners interviewed during the pilot tests. To make it easier for vendors to monitor attendance, Sirma Mobile has developed a mobile application ...

Anti-HIV drug use during pregnancy does not affect infant size, birth weight

2012-05-02
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study. However, at 1 year of age, children born to the tenofovir-treated mothers were slightly shorter and had slightly smaller head circumference—about 1 centimeter each, on average—than were infants whose mothers did not take tenofovir. ...

Researchers gain better understanding of mechanism behind tau spreading in the brain

2012-05-02
Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function. Previous studies have shown that the abnormal folding, or misfolding, and buildup of tau are key neuropathological features ...

Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma

2012-05-02
Low dose whole body CT is nearly four times better than radiographic skeletal survey, the standard of care in the U.S., for determining the extent of disease in patients with multiple myeloma, a new study shows. The study, conducted at the University of Maryland in Baltimore, included 51 patients who had both a radiographic skeletal survey as well as a low dose whole body CT examination. The total number of lesions detected in these patients with low dose whole body CT was 968 versus 248 detected by radiographic skeletal survey, said Kelechi Princewill, MD, the lead author ...

Michaels Inspires Dads With Easy Ideas for Handmade Mother's Day Gifts

Michaels Inspires Dads With Easy Ideas for Handmade Mothers Day Gifts
2012-05-02
Dad may be better with a hammer than a glue gun, but Michaels makes it easy for dads to help their children create special Mother's Day gifts for Mom. With hundreds of DIY gift ideas online and low-cost in-store gift-making events from Michaels, dads and their children will have fun creating a memorable handmade gift. Dads with an artistic flair can help their children create personalized handmade cards, while dads and kids with green thumbs can embellish garden stepping stones. From decorated mugs to custom designed apparel to festive cupcakes, Michaels features quick ...

Cone beam CT proves better for visualizing some causes of hearing loss at half the radiation dose

2012-05-02
Cone beam CT is superior to mutidetector CT for detecting superior semicircular canal dehiscence or the so called third window (a small hole in the bony wall of the inner ear bone that can cause dizziness and hearing loss) and it uses half the radiation dose, a new study shows. The study, conducted in Bruges, Belgium, included 21 patients who had both a cone beam CT and a multidetector CT examination of their right and left temporal bones, said David Volders, MD, one of the authors of the study. Two radiologists reviewed the images from both exams and scored them based ...

Soft & Shield Hand Sanitizer and Moisturizer, a Safe and Healthy Alternative to Alcohol Based Hand Sanitizers

Soft & Shield Hand Sanitizer and Moisturizer, a Safe and Healthy Alternative to Alcohol Based Hand Sanitizers
2012-05-02
The current news and publicity of teenagers consuming alcohol based hand sanitizers in an effort to get intoxicated has alarmed parents. In addition, there have been recent reports of many cases of alcohol poisoning by children under 5 from ingesting alcohol hand sanitizers. We believe consumers are seeking a superior and safer product for their families to use. Many public health officials are becoming worried that these types of incidents could be evidence of a dangerous and serious new fad. With these alarming new reports, we believe concerned parents need a safer ...

JCI early table of contents for April 30, 2012

2012-05-01
ONCOLOGY Lymphoma therapy could deliver a double punch | Back to top B cell lymphomas are a group of cancers of that originate in lymphoid tissue from B cells, the specialized immune cell type that produces antibodies. The development of B cell lymphoma is associated with several known genetic changes, including increased expression of MYC, a transcription factor that promotes cell growth and division. In this issue of the JCI, Andrei Thomas-Tikhonenko and his colleagues at the University of Pennsylvania in Philadelphia report on their studies to better understand the ...

UC Davis researchers create molecule that blocks pathway leading to Alzheimer's disease

2012-05-01
UC Davis researchers have found novel compounds that disrupt the formation of amyloid, the clumps of protein in the brains of people with Alzheimer's disease believed to be important in causing the disease's characteristic mental decline. The so-called "spin-labeled fluorene compounds" are an important new target for researchers and physicians focused on diagnosing, treating and studying the disease. The study, published today in the online journal PLoS ONE, is entitled "The influence of spin-labeled fluorene compounds on the assembly and toxicity of the Aβ peptide." "We ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance